LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,208,227 | -42.5% | 20,164 | -30.8% | 0.01% | -35.7% |
| Q2 2023 | $2,100,057 | +1.1% | 29,127 | +3.2% | 0.01% | -6.7% |
| Q1 2023 | $2,076,378 | +6.5% | 28,227 | -3.3% | 0.02% | 0.0% |
| Q4 2022 | $1,950,426 | +76931.0% | 29,198 | -0.7% | 0.02% | -28.6% |
| Q3 2022 | $2,532 | -99.9% | 29,400 | -5.8% | 0.02% | -12.5% |
| Q2 2022 | $2,784,000 | -20.7% | 31,200 | 0.0% | 0.02% | +14.3% |
| Q1 2022 | $3,510,000 | -33.2% | 31,200 | -8.3% | 0.02% | -25.0% |
| Q4 2021 | $5,258,000 | +12.0% | 34,040 | +1.0% | 0.03% | +3.7% |
| Q3 2021 | $4,695,000 | +744.4% | 33,700 | +823.8% | 0.03% | +575.0% |
| Q1 2021 | $556,000 | -5.8% | 3,648 | -38.5% | 0.00% | -20.0% |
| Q4 2020 | $590,000 | -66.2% | 5,936 | -57.3% | 0.01% | -68.8% |
| Q1 2019 | $1,747,000 | +23.1% | 13,900 | +33.0% | 0.02% | +33.3% |
| Q4 2018 | $1,419,000 | -74.0% | 10,455 | -47.5% | 0.01% | -68.4% |
| Q3 2018 | $5,465,000 | +26.3% | 19,908 | -4.7% | 0.04% | +31.0% |
| Q2 2018 | $4,327,000 | +91.4% | 20,887 | +52.6% | 0.03% | +81.2% |
| Q1 2018 | $2,261,000 | -7.7% | 13,687 | -23.5% | 0.02% | 0.0% |
| Q4 2017 | $2,449,000 | +36.4% | 17,887 | +35.6% | 0.02% | +100.0% |
| Q3 2017 | $1,795,000 | +50.2% | 13,187 | +33.9% | 0.01% | -20.0% |
| Q2 2017 | $1,195,000 | -18.5% | 9,847 | -28.9% | 0.01% | -23.1% |
| Q1 2017 | $1,466,000 | +7.3% | 13,847 | +3.0% | 0.01% | 0.0% |
| Q4 2016 | $1,366,000 | -0.4% | 13,447 | 0.0% | 0.01% | -7.1% |
| Q3 2016 | $1,372,000 | -14.5% | 13,447 | 0.0% | 0.01% | -22.2% |
| Q2 2016 | $1,604,000 | +16.6% | 13,447 | +4.7% | 0.02% | +20.0% |
| Q1 2016 | $1,376,000 | -1.2% | 12,847 | 0.0% | 0.02% | +36.4% |
| Q4 2015 | $1,393,000 | -18.4% | 12,847 | -35.6% | 0.01% | -26.7% |
| Q3 2015 | $1,708,000 | -39.0% | 19,947 | -28.1% | 0.02% | -25.0% |
| Q2 2015 | $2,800,000 | +7.6% | 27,747 | -17.8% | 0.02% | +5.3% |
| Q1 2015 | $2,602,000 | +42.3% | 33,747 | -1.7% | 0.02% | +58.3% |
| Q4 2014 | $1,828,000 | +9.7% | 34,347 | -3.1% | 0.01% | +9.1% |
| Q3 2014 | $1,666,000 | -41.3% | 35,447 | -22.2% | 0.01% | -35.3% |
| Q2 2014 | $2,837,000 | +1.4% | 45,547 | +9.5% | 0.02% | -5.6% |
| Q1 2014 | $2,798,000 | +7.0% | 41,600 | -16.3% | 0.02% | +12.5% |
| Q4 2013 | $2,614,000 | – | 49,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |